ERK3/MAPK6 controls IL-8 production and chemotaxis

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Extracellular signal-regulated kinase 3 (ERK3) is an atypical mitogen-activated protein kinase (MAPK) with a short half-life.
• The physiological role of ERK3, particularly its stability and function during epithelial differentiation and in disease, is not well understood.

Purpose of the Study:

• To investigate the role of ERK3 in human gastric epithelial differentiation and tumorigenesis.
• To elucidate the mechanisms by which ERK3 influences cellular signaling, secretome composition, and metastatic potential.

Main Methods:

• Utilized 3D gastrointestinal organoid models for studying epithelial differentiation.
• Employed techniques to assess ERK3 protein levels, activation, and its interaction with c-Jun.
• Analyzed the impact of ERK3 deficiency on cellular secretome and chemotaxis in vitro and in vivo.
• Investigated ERK3's role in the metastatic potential of breast cancer cells.

Main Results:

• ERK3 protein levels decrease during normal epithelial differentiation but are stabilized and activated in tumorigenic cells.
• ERK3 is essential for the production of interleukin-8 (IL-8) and regulates AP-1 signaling via c-Jun.
• ERK3-deficient cells exhibit a defective secretome, impairing neutrophil and monocyte chemotaxis.
• Knockdown of ERK3 reduces the metastatic potential of invasive breast cancer cells.

Conclusions:

• ERK3 plays a critical role in regulating the epithelial secretome, specifically IL-8 production, which influences immune cell chemotaxis.
• ERK3 stabilization in cancer cells suggests a role in tumorigenesis and metastasis.
• These findings highlight ERK3 as a potential therapeutic target for modulating immune responses and cancer progression.